Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Duration of Response in a Phase 3 Study of Sarilumab Plus Methotrexate in Patients with Active, Moderate-to-Severe Rheumatoid Arthritis Genovese, M. C., Mangan, E. K., Kimura, T., Iglesias-Rodriguez, M., Huizinga, T. J. WILEY. 2017
View details for Web of Science ID 000411824105321